Course for professionals

MRCRM seminar series - August 2022

PI Cecilie Bredrup will give a talk about her TMF funded project "Mesenchymal stem cells transplantation in wound healing". In her talk, she will discuss cell based therapies for limbal stem cell deficiency (LSCD).

  1. 30. Aug 2022, 2:30 PM - 3:30 PM

Time and place


  1. 30. Aug 2022, 2:30 PM - 3:30 PM

Event type



Øyesykdommer, Immunologi og transfusjonsmedisin


Mohn Research Centre for Regenerative Medicine
Title: Mesenchymal stem cell transplantation in limbal stem cell deficiency - Development of precision medicine

Abstract: Limbal stem cell deficiency (LSCD) causes discomfort and reduced vision and is a major problem in ophthalmology. Today, the treatment is transplantation of allogenic limbal stem cells, but this has its limitations. 
Mesenchymal stem cells are now emerging as a promising treatment option. The phase 1 clinical trial using these cells in patients with end-stage LSCD will be presented. 

Portrait Cecilie Bredrup. Photo

About the speaker: Cecilie Bredrup is an Ophthalmologist at Haukeland University Hospital and an associate professor at University of Bergen. She did her PhD in 2009 in Bergen, with the thesis "Clinical and molecular aspects of congenital hereditary eye disease".  
More about Dr Bredrup's work here

One of the four core projects of MRCRM is led by Dr Bredrup. More about the project here